SNGX compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

SNGXSoligenix, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

SNGXSoligenix, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SNGX 8

—New York Universityunlistedsupplier

—SERB Pharmaceuticalsunlistedsupplier

—University of British Columbiaunlistedsupplier

—University of Texas Southwestern Medical Centerunlistedsupplier

4 more · SNGX chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

SNGXSoligenix, Inc.

0.33▼−4.87%· post 0.33

Mkt cap$7.6MRevenue$2,342Q2 FY24Revenue—

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

ClosedNov 5 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 5 '26

SNGXSoligenix, Inc.

LLYELI Lilly & Co

0.33▼−4.87%post 0.33

Price

1,371.32▼−3.29%post 1,363.77

$7.6M

Mkt cap

$1.2T

Q2 FY24$2,342

Revenue

$24.4BQ3 FY26

—

Revenue

$65.2BFY25

SNGX0.33▼−4.87%vsLLY1,371.32▼−3.29%ClosedNov 5 '26